The Crossbow Therapeutics, Inc team enjoying its summer outing on the Charles River on a beautiful afternoon! It’s always a great to take time to socialize and have some fun together. Special thanks to Sarah Jaffe for making this happen!!
Crossbow Therapeutics, Inc
Biotechnology Research
Cambridge, MA 3,616 followers
Established antibody engineering to target the untapped universe of intracellular cancer targets, founded by MPM Capital
Über uns
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.
- Website
-
http://www.crossbowtx.com
External link for Crossbow Therapeutics, Inc
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Cambridge, MA
- Typ
- In Privatbesitz
- Gegründet
- 2021
Standorte
-
Primäre
1030 Massachusetts Avenue
Suite 210
Cambridge, MA 02138, US
Employees at Crossbow Therapeutics, Inc
Aktualisierungen
-
Say hello to the newest members of the #Finance team at Crossbow Therapeutics, Inc. We are delighted to welcome Anita Valente, CPA and Tatiana Vales. Their contributions will keep us on target as we collectively work towards our mission of broadening the benefits of #immunotherapy and improving the lives of people living with #cancer.
-
-
Introducing the newest members of Crossbow Therapeutics, Inc! Please join us in welcoming Brendan Whalen to the #Antibody Discovery, #Protein Engineering, and #ProcessDevelopment (ADPEPD) team and Emily McNally to the #Biology group. We are confident that their experience will move us towards our mission of broadening the benefits of #immunotherapy and improving the lives of people living with #cancer.
-
-
We're #hiring! Come join my team at Crossbow Therapeutics, Inc! This is an exciting role spanning #ProgramManagement, #RnDOperations, #CorporateOperations, competitive intelligence and more! We're a dynamic, collaborative and innovative #biotech team that is boldly pushing to bring new #medicines to patients. If this sounds like a match, don't hesitate to #apply!
We are #hiring at Crossbow Therapeutics, Inc! Our Co-founder, VP of Corporate Development and Operations, Geraldine Paulus, is looking to bring on board an exciting new role as a senior manager or associate director, corporate operations and program management. Find out more about the position and how to apply in the Job Posting below.
-
We are #hiring at Crossbow Therapeutics, Inc! Our Co-founder, VP of Corporate Development and Operations, Geraldine Paulus, is looking to bring on board an exciting new role as a senior manager or associate director, corporate operations and program management. Find out more about the position and how to apply in the Job Posting below.
-
We are delighted to announce that Dr. Charles Baum, MD, PhD has joined Crossbow Therapeutics, Inc's #board as an independent director. Chuck is an accomplished #biopharma exec who brings over 30 years of experience in #oncology and we look forward to benefitting from his deep expertise. You can find his full bio on our website's team section: https://lnkd.in/euQ2u9Fp
-
-
We are #hiring at Crossbow Therapeutics, Inc! Our antibody discovery, protein engineering and process development team is looking to bring on board a Sr. RA or Associate Scientist in Protein Analytics. Find out more about the position and how to apply in the Job Posting below. #cancer #immunooncology #antibody #protein #analytics
-
We are #hiring at Crossbow Therapeutics, Inc! Our head of Translational Medicine, Benjamin Lee is looking to bring on board an associate director to his team. Find out more about the position and how to apply in the Job Posting below. #cancer #translational medicine #immunooncology
-
We're excited to be featured by BioCentury Inc. in one of the Emerging Company Profiles. Briggs Morrison, Dmitri Wiederschain and Geraldine Paulus enjoyed speaking with Karen Tkach Tuzman to discuss Crossbow Therapeutics, Inc's approach to open up the target space in oncology as well as its first drug candidate CBX-250. Read the full article here: https://lnkd.in/eEpPAvxV
-
Last week, our head of Translational Medicine, Benjamin Lee, gave a talk at the 6th Annual Cell Engager Summit (https://lnkd.in/eSZynx9) in Boston. Another great opportunity to highlight Crossbow Therapeutics, Inc's lead program, CBX-250, a novel T cell engager targeting a peptide-HLA complex for the treatment of #AML and other heme malignancies!
-